Verywell Health on MSN3d
What's New in Alzheimer's Treatment?
We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...
Might Xenon gas be useful for treating Alzheimer’s, as a new study suggests?
Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an ...
verywellhealth7h
Why It's Hard for Patients to Get the Newest Alzheimer's Drugs
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...
Rolling Out1d
Alzheimer’s new nasal spray stops memory loss
Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...
Axiom Brain Health opens larger site for neurodegenerative disease research in Tampa
One year after being acquired by Global Alzheimer’s Platform Innovations, Tampa-based Axiom Brain Health has expanded its ...
The American Journal of Managed Care9h
FDA Approves New Maintenance Dosing for Lecanemab to Treat Early-Stage Alzheimer Disease
The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...
Pharm Exec8h
FDA Approves Supplemental Biologics License Application for Intravenous Maintenance Dosing of Leqembi in Alzheimer Disease
Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...
New York Post11d
‘Novel approach’ to treating Alzheimer’s disease discovered — it’s a gas
Sandor Kacso - stock.adobe.com Breathe easy — researchers say they may have found an innovative approach to treating ...
Medical Xpress on MSN12d
Xenon gas shows promise in Alzheimer's treatment, leading to clinical trial
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...
BioArctic: FDA approves IV maintenance dosing of Leqembi (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US
BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's ...
Science Daily4d
Researchers create new guidelines to diagnose common memory disorder frequently mistaken for Alzheimer's Disease
New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant ...